You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
By Adam Bonislawski
According to a report commissioned by proteomics firm Proteome Sciences, protein biomarkers for Alzheimer's disease will represent a cumulative $9 billion market over the next ten years.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.
Recent advances in spatially resolved transcriptomics have greatly expanded the knowledge of complex multicellular biological systems.